Substances and chemicals that are required during the genomic sequencing protocols are called sequencing reagents. They have functions for initiation/detection of the DNA segment, sustenance of DNA fragmentation, and reaction termination.
The covid-19 pandemic brought positive growth in this sector which is expected to grow further in the next few years.
The sequencing reagents market size was estimated to be US$ 6.5 billion in 2021.
The global sequencing reagents market is estimated to exhibit a CAGR of 12.5% between 2023 to 2032.
The next-generation sequencing (NGS) platforms have the highest market share of sequencing services, and this can be attributed to it being common practice for molecular diagnostics, molecular pathology, and clinical research applications.
Major players involved in the sequencing market are Avantor, Inc., Agilent Technologies, Inc., BioChain Institute Inc., BioLegend, Inc., FroggaBio Inc., F. Hoffmann-La Roche Ltd, Fluidigm Corporation, Illumina, Inc., LGC Limited, Meridian, Merck KGaA, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, QIAGEN, Pacific Biosciences of California, Inc., New England Biolabs, TriLink BioTechnologies, Tecan Trading AG, Takara Bio Inc., and others.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved